Valturna and Omeprazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Valturna (aliskiren hemifumarate; valsartan) and Omeprazole (omeprazole). Common drug interactions include cellulitis among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Valturna and Omeprazole. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.
What is Valturna?
Valturna has active ingredients of aliskiren hemifumarate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 619 Valturna users. Check the latest studies of Valturna.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.
39 people who take Valturna and Omeprazole together, and have interactions are studied.

What are the common drug interactions of Valturna and Omeprazole, by gender? *:
female:
- Cellulitis (infection under the skin)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Folliculitis (infection of hair root)
- Hyperkalaemia (damage to or disease of the kidney)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Juvenile arthritis (arthritis-related condition that develops in children or teenagers)
- Oedema peripheral (superficial swelling)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Pancreatic mass
male:
- Chronic kidney disease
- Blood creatinine increased
- Kidney enlargement
- Pain in extremity
- Renal failure acute (rapid kidney dysfunction)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Renal failure (kidney dysfunction)
- Abdominal pain
- Anaemia (lack of blood)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
What are the common drug interactions of Valturna and Omeprazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Arrhythmia (irregular heartbeat)
- Arthralgia (joint pain)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Blood creatinine increased
- Bradycardia (abnormally slow heart action)
- Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
- Cellulitis (infection under the skin)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Cough
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
60+:
- Death
- Alanine aminotransferase increased
- Diarrhoea
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Infection
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Parkinson's disease
- Blood pressure inadequately controlled
- Blood pressure systolic increased
- Breast cancer recurrent
What are the existing conditions these people have? *
- Pain: 7 people, 17.95%
- Infection: 5 people, 12.82%
- High Blood Cholesterol: 5 people, 12.82%
- Diabetes: 5 people, 12.82%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 5 people, 12.82%
- Cough: 4 people, 10.26%
- Hypokalemia (low potassium): 4 people, 10.26%
- Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 3 people, 7.69%
- Erection Problems: 3 people, 7.69%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Valturna and Omeprazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Valturna (619 reports)
- Omeprazole (410,631 reports)
Browse all drug interactions of Valturna and Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Valturna:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Valturna and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on aliskiren hemifumarate; valsartan and omeprazole (the active ingredients of Valturna and Omeprazole, respectively), and Valturna and Omeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Analgesic Therapy and Fall - 8 seconds ago
- Could Mycophenolate Mofetil cause Transferrin Saturation Decreased? - 12 seconds ago
- Anaemia and Skin Infection - 12 seconds ago
- Could Aripiprazole cause Protein - Urine? - 19 seconds ago
- Drug interactions of Mycophenolate Mofetil and Requip - 24 seconds ago
- Could Glyburide cause Muscle Atrophy? - 25 seconds ago
- Acute Myeloid Leukaemia Recurrent and Acute Myeloid Leukaemia - 35 seconds ago
- Vyvanse vs. Fish Oil, side effect and effectiveness comparison - 39 seconds ago
- Could Benzonatate cause Micturition Frequency Decreased? - 42 seconds ago
- Could Seroquel Xr cause Mood Swings? - 45 seconds ago